News & Updates
Filter by Specialty:

Gemcitabine for IR-NMIBC tied to more recurrence vs BCG
06 Jun 2025
byStephen Padilla
Treatment-naive patients with immediate-risk (IR) nonmuscle-invasive bladder cancer (NMIBC) who received gemcitabine appear to have greater recurrence risk than those given Bacillus Calmette-Guerin (BCG). Both treatments, however, are effective against disease progression.
Gemcitabine for IR-NMIBC tied to more recurrence vs BCG
06 Jun 2025
BGF initiation after an exacerbation in COPD: Does timing matter?
06 Jun 2025
byAudrey Abella
Findings from the MITOS EROS+CP (US) study underscore the importance of prompt initiation of budesonide/glycopyrrolate/formoterol fumarate (BGF) following an exacerbation in patients with chronic obstructive pulmonary disease (COPD).